Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3‐year postmarketing study

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|21|4|481-489

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.21, Iss.4, 2015-07, pp. : 481-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre

By  

HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. : 496-501

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factor XI‐related thrombosis and the role of concentrate treatment in factor XI deficiency

By  

HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. : 477-480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Perioperative management of a redo aortic root replacement in a patient with severe factor XI deficiency

By  

JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol. 33, Iss. 2, 2018-02 ,pp. : 86-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1047-1051

John Wiley & Sons Inc

Access to resources Recommend Favorite

Percutaneous Coronary Intervention in a Patient with Congenital Factor XI Deficiency and Acquired Inhibitor

By  

Cardiology, Vol. 107, Iss. 1, 2006-06 ,pp. : 69-72

Karger

Access to resources Recommend Favorite